DCAT Value Chain Insights

Pharma Company on the Move: Alnylam Pharmaceuticals

Buoyed by $2 billion in funding by the private equity firm, Blackstone, a $1-billion partnering deal with Regeneron Pharmaceuticals, and potential gains from a possible blockbuster anti-cholesterol...

The FDA Advises on GMP, Manufacturing and COVID-19

The FDA has issued guidance to advise drug manufacturers how to resume normal manufacturing operations that were impacted by the COVID-19 pandemic, which has caused unusual challenges: employee...

SPONSORED CONTENT

New Choices to Help Improve mAbs Downstream Manufacturing Efficiency: Introducing the J.T.Baker® BAKERBOND® PROchievA™ Recombinant Protein A Resin

Information
September 23, 2020
Sponsored by Avantor

An integrated mAbs downstream purification process featuring Avantor J.T.Baker® BAKERBOND® PROchievA™ recombinant protein A chromatography columns and resins can enable significant throughput...

Read More
Small-Molecule Matters: Integration in Drug Development

Information
September 8, 2020
Sponsored by Cambrex

How a collaborative approach between small and large drug developers with the right CDMO can overcome critical challenges to achieve greater efficiencies in quality, time, and cost – at every stage...

Read More
COVID-19 and What’s Next for API Sourcing?

Information
September 2, 2020
Sponsored by Dr. Reddy's Laboratories

The pandemic challenged the global supply chain instantly. Geopolitical tensions and the call for localizations and self-reliance are further adding to the complexity of today’s API souring. In this...

Read More